دورية أكاديمية
Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma
| العنوان: | Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma |
|---|---|
| المؤلفون: | Nakazato, TomonoriAff1, Hagihara, Masao, Sahara, Naohi, Tamai, Yotaro, Ishii, Ryuji, Tamaki, Shigehisa, Wake, Atsushi, Tajika, Kenji, Sakai, Rika, Kobayashi, Takeshi, Hua, Jian, Inoue, Morihiro, Aisa, Yoshinobu, Fujisawa, Shin, Miyazaki, Koji, Irie, Seiji, Tanaka, Eri, Higashihara, Masaaki |
| المصدر: | Annals of Hematology. 100(11):2745-2754 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 09395555 14320584 |
|---|---|
| DOI: | 10.1007/s00277-021-04592-y |